Burkholderia cepacia complex infection in an Adult Cystic Fibrosis unit in Madrid

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 31, Issue 10, 2013, Pages 649-654

  Correa Ruiz, Ana ^a   Girón, Rosa ^b   Buendía, Buenaventura ^a   Medina Pascual, M José ^c   Valenzuela, Claudia ^b   López Brea, Manuel ^a   Sáez Nieto, Juan Antonio ^c  

^a Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Burkholderia cepacia complex; Cystic fibrosis; Lung function; Molecular methods

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA CEPACIA INFECTION; BURKHOLDERIA CONTAMINANS; BURKHOLDERIA LATE; BURKHOLDERIA MULTIVORANS; BURKHOLDERIA STABILIS; BURKHOLDERIA VIETNAMIENSIS; CLINICAL ARTICLE; FEMALE; GENOTYPE; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; MALE; NONHUMAN; SPAIN; STAPHYLOCOCCUS AUREUS; BURKHOLDERIA INFECTIONS; CLASSIFICATION; COMPLICATION; CYSTIC FIBROSIS; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; YOUNG ADULT;

ADULT; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; SPAIN; YOUNG ADULT;

EID: 84889605834     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2012.12.001     Document Type: Article

References (41)

1. N. Norskov-Lauritsen, H. Krogh Johansen, M.G. Fenger, X.C. Nielsen, T. Pressler, and H.V. Olesen Unusual distribution of Burkholderia cepacia complex species in Danish cystic fibrosis clinics may stem from restricted transmission between patients J Clin Microbiol 48 2010 2981 2983
2. J.J. LiPuma, S.E. Dase, D.W. Nielsol, R.C. Stern, and T.L. Stull Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis Lancet 336 1990 1094 1096
3. J.R.W. Goval, P.H. Brown, J. Maddison, C.J. Doherty, J.W. Nelson, and M. Dodd Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis Lancet 342 1993 15 19
4. P. Vandamme, B. Holmes, M. Vancanneyt, T. Coenye, B. Hoste, and Coopman R. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp Int J Syst Bacteriol 47 1997 1188 1200
5. T. Coenye, P. Vandamme, J.R.W. Govan, and J.J. LiPuma Taxonomy and identification of the Burkholderia cepacia complex J Clin Microbiol 39 2001 3427 3436
6. E. Vanlaere, J.J. LiPuma, A. Baldwin, D. Henry, E. De Brandt, and E. Maahanthiralingam Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex Int J Syst Evol Microbiol 58 2008 1580 1590
7. E. Vanlaere, A. Baldwin, D. Gevers, D. Hery, E. De Brandt, and J.J. LiPumm Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol 59 2009 102 111
8. H. Rose, A. Baldwin, C.G. Dowson, and E. Mahenthiralingam Biocide susceptibility of the Burkholderia cepacia complex J Antimicrob Chemother 63 2009 502 510
9. E. Mahenthiralingham, A. Baldwin, and P. Vandamme Burkholderia cepacia complex infection in patients with cystic fibrosis J Med Microbiol 51 2002 533 538
10. P. Drevinek, and E. Mahenthiralingam Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence Eur J Clin Microbiol Infect Dis 16 2010 821 830
11. R.N. Chernish, and S.D. Aaron Approach to resistant gram-negative bacterial pulmonary infections in patients with cystic fibrosis Curr Opin Pulm Med 9 2003 509 515
12. D.P. Speert Advances in Burkholderia cepacia complex Paediatr Respir Rev 3 2002 230 235
13. S. Nzula, P. Vandamme, and J.R. Goman Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex J Antimicrob Chemother 50 2002 265 269
14. E. Mahenthiralingam, T.A. Urban, and J.B. Goldberg The multifarious, multireplicon Burkholderia cepacia complex Nat Rev Microbiol 3 2005 144 156
15. B.A.D. Conway, V. Venu, and D.P. Speert Biofilm formation and acyl homoserine lactone production in the Burkholderia cepacia complex J Bacteriol 184 2002 5678 5685
16. K.L. Tomlin, S.R.D. Clark, and H. Ceri Green and red fluorescent protein vectors for use in biofilm studies of the intrinsically resistant Burkholderia cepacia complex J Microbiol Methods 57 2004 95 106
17. S.D. Aaron, W. Ferris, D.A. Henry, D.P. Speert, and N. MacDonald Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia Am J Respir Crit Care Med 161 2000 1206 1212
18. J. Zhou, Y. Chen, S. Tabibi, L. Alba, E. Garber, and L. Saiman Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis Antimicrob Agents Chemother 51 2007 1085 1088
19. S. Correia, C. Nascimento, L. Pereira, M.V. Cunha, I. Sá-Correia, and C. Barrreto The clinical course of Burkholderia cepacia complex bacteria respiratoriy infection in cystic fibrosis patients Rev Port Pneumol 14 2008 5 26
20. J.J. LiPuma Burkholderia cepacia. Management issues and new insights Clin Chest Med 19 1998 473 486
21. P.G. Middleton, T.J. Kidd, and B. Williams Combination aerosol therapy to treat Burkholderia cepacia complex Eur Respir J 26 2005 305 308
22. K. Bromley Antibiotic treatment for cystic fibrosis, report of the UK Cystic Fibrosis Trust Antibiotic Group 2nd ed. 2002 Cystic Fibrosis Trust UK
23. A. Oliver, T. Alarcón, E. Caballero, and R. Canton Diagnóstico microbiológico de la colonización- infección broncopulmonar en el paciente con fibrosis quística Enferm Infecc Microbiol Clin 27 2009 89 104
24. A. McGregor, F. Schio, S. Beaton, V. Boulton, M. Perman, and G. Gilber The MicroScan WalkAway diagnostic microbiology system-an evaluation Pathology 27 1995 172 176
25. W.G. Weisburg, S. Barns, D.A. Pelletier, and D.J. Lane 16S ribosomal DNA amplification for phylogenetic study J Bacteriol 173 1991 697 703
26. E. Mahenthiralingam, J. Bischof, S.K. Byrne, C. Radomski, J.E. Davies, and Y. Av-Gay DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genovars I and III J Clin Microbiol 38 2000 3165 3173
27. S. Valdezate, A. Vindel, L. Maiz, F. Baquero, H. Escobar, and R. Cantón Persistence and variability of Stenotrophomonas maltophilia in Cystic Fibrosis in Madrid, 1991-1998 Emerg Infect Dis 7 2001 113 122
28. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement M100-S22 2012 Clinical and Laboratory Standards Institute
29. B. Gómez, A. Gómez, N. Martínez, M. Santiago, A. Sojo, and J. Barrón Infección por el complejo Burkholderia Cepacia en la Fibrosis Quística Arch Bronconeumol 48 2012 218
30. C. Van Pelt, C.M. Verduin, W.H.F. Goessens, M.C. Vos, B. Tummler, and C. Segonds Identification of Burkholderia spp. In the Clinical Microbiology Laboratory: comparison of conventional and molecular methods J Clin Microbiol 37 1999 2158 2164
31. A.M. Jones, M.E. Dodd, J.R.W. Govan, V. Barcus, C.J. Doherty, and J. Morris Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis Thorax 59 2004 948 951
32. O.C. Tablan, W.J. Martone, C.F. Doershuk, R.C. Stern, M.J. Thomassen, and J.D. Klinger Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes Chest 91 1997 133 134
33. J.J. LiPuma, D.A. Marks-Austin, D.S. Holsclaw, and D.P. Speert Inaparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis Pediatr Infect Dis J 13 1994 716
34. M. Desai, T. Bühler, P.H. Weller, and M.R. Brown Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth J Antimicrob Chemother 42 1998 153 160
35. E. Peeters, H.J. Nelis, and T. Coenye In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/ sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria J Antimicrob Chemother 63 2009 801 809
36. A.L. Spoering, and K. Lewis Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials J Bacteriol 183 2001 6746 6751
37. J. Eisenberg, M. Pepe, J. Williams-Warren, M. Vasiliev, A.B. Montgomery, and A.L. Smith A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems Chest 111 1997 955 962
38. D.E. Geller, M. Rosenfeld, D.A. Waltz, and R.W. Wilmott Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system Chest 123 2003 28 36
39. A. Weidmann, A.K. Webb, M.E. Dodd, and A.M. Jones Successful treatment of cepacia syndrome with combination nebulized and intravenous antibiotic therapy J Cyst Fibros 7 2008 409 411
40. D.A. Henry, M.E. Campbell, J.J. LiPuma, and D.P. Speert Identification of Burkholdria cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium J Clin Microbiol 35 1997 614 619
41. L. Jimenez Microbial diversity in pharmaceutical product recalls and environments PDA J Pharm Sci Technol 61 2007 383 399